Qube Research & Technologies (QRT)’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELVN
Qube Research & Technologies (QRT)'s ELVN Position: Q3 2026 in Review
Qube Research & Technologies (QRT) opened a new position in Enliven Therapeutics (ELVN) in Q3 2026: 287,543 shares worth $13.2M. The stake represents 0.01% of the portfolio and ranks #1269 among its holdings.
216 funds tracked by Wall St. Rank hold ELVN as of Q3 2026.
- Qube Research & Technologies (QRT) held 287,543 shares of Enliven Therapeutics worth $13.2M as of Q3 2026.
- Enliven Therapeutics was a new Qube Research & Technologies (QRT) position in Q3 2026.
- Enliven Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1269 holding.
- 216 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.